Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Differential washout of FDG activity in two different inflammatory lesions: implications for delayed imaging.

Cheng G, Alavi A, Del Bello CV, Akers SR.

Clin Nucl Med. 2013 Jul;38(7):576-9. doi: 10.1097/RLU.0b013e318292efc8.

PMID:
23640221
2.

Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.

Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A.

Ann Nucl Med. 2009 Nov;23(9):783-91. doi: 10.1007/s12149-009-0305-x. Epub 2009 Oct 16.

PMID:
19834653
3.

The role of FDG PET-CT in differential diagnosis of pleural pathologies.

Elboga U, Yılmaz M, Uyar M, Zeki Çelen Y, Bakır K, Dikensoy O.

Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):187-91. doi: 10.1016/j.remn.2011.06.002. Epub 2011 Sep 22.

4.

Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.

Zhao S, Kuge Y, Kohanawa M, Takahashi T, Zhao Y, Yi M, Kanegae K, Seki K, Tamaki N.

J Nucl Med. 2008 Jan;49(1):135-41. Epub 2007 Dec 12.

5.

Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.

Abe Y, Tamura K, Sakata I, Ishida J, Ozeki Y, Tamura A, Uematsu K, Sakai H, Goya T, Kanazawa M, Machida K.

Oncol Rep. 2012 Feb;27(2):333-8. doi: 10.3892/or.2011.1520. Epub 2011 Oct 24.

PMID:
22024889
6.

Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease.

Huber H, Hodolic M, Stelzmüller I, Wunn R, Hatzl M, Fellner F, Lamprecht B, Rubello D, Colletti PM, Gabriel M.

Nucl Med Commun. 2015 May;36(5):430-7. doi: 10.1097/MNM.0000000000000274.

PMID:
25646704
7.

Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.

Kim M, Achmad A, Higuchi T, Arisaka Y, Yokoo H, Yokoo S, Tsushima Y.

J Nucl Med. 2015 Jan;56(1):16-21. doi: 10.2967/jnumed.114.144014. Epub 2014 Dec 4.

8.

Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.

Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS.

J Oral Maxillofac Surg. 2014 Oct;72(10):1957-65. doi: 10.1016/j.joms.2014.04.017. Epub 2014 Apr 24.

PMID:
25053572
9.

MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.

Dong A, Dong H, Wang Y, Gong J, Lu J, Zuo C.

Clin Nucl Med. 2013 Feb;38(2):e66-73. doi: 10.1097/RLU.0b013e318266ceca.

PMID:
22996250
10.

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM.

Arch Dermatol. 2011 Sep;147(9):1031-9. doi: 10.1001/archdermatol.2011.119. Epub 2011 May 16.

11.

Suture granuloma showing false-positive finding on PET/CT after head and neck cancer surgery.

Kikuchi M, Nakamoto Y, Shinohara S, Fujiwara K, Tona Y, Yamazaki H, Kanazawa Y, Kurihara R, Imai Y, Naito Y.

Auris Nasus Larynx. 2012 Feb;39(1):94-7. doi: 10.1016/j.anl.2011.04.012. Epub 2011 May 28.

PMID:
21620597
13.

Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.

J Gastroenterol Hepatol. 2013 Feb;28(2):255-61. doi: 10.1111/jgh.12068.

PMID:
23278193
14.

Detection of the inflammatory process in a Behçet's disease-like mouse model using 18F-fluorodeoxyglucose positron emission tomography.

Cho SB, Sohn S, Zheng Z, Cho A, Kim H, Kang WJ, Bang D, Yun M, Lee JD, Lee JH.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):47-53. Epub 2013 Jun 5.

PMID:
23739526
15.

18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.

Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, De Luca S, Pane F, Salvatore M, Del Vecchio S.

Clin Nucl Med. 2015 Apr;40(4):303-8. doi: 10.1097/RLU.0000000000000696.

PMID:
25608167
16.

Extra-articular inflammatory sites detected by F-18 FDG PET/CT in a patient with rheumatoid arthritis.

dos Anjos DA, do Vale GF, Campos Cde M, do Prado LF, Sobrinho AB, da Cunha AL, Santos AC.

Clin Nucl Med. 2010 Jul;35(7):540-1. doi: 10.1097/RLU.0b013e3181e05eb9. No abstract available.

PMID:
20548154
17.

Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.

Ito K, Okazaki O, Morooka M, Kubota K, Minamimoto R, Hiroe M.

Intern Med. 2014;53(18):2041-9. Epub 2014 Sep 15.

18.

Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Ito K, Minamimoto R, Yamashita H, Yoshida S, Morooka M, Okasaki M, Mimori A, Kubota K.

Ann Nucl Med. 2013 Apr;27(3):209-16. doi: 10.1007/s12149-012-0675-3. Epub 2012 Dec 16.

19.

Role of delayed imaging to differentiate intense physiological 18F FDG uptake from peritoneal deposits in patients presenting with intestinal obstruction.

Zade A, Purandare N, Rangarajan V, Shah S, Agarwal A, Kulkarni M, Jha AK.

Clin Nucl Med. 2012 Aug;37(8):783-5. doi: 10.1097/RLU.0b013e31824c5e7d.

PMID:
22785511
20.

False positive 18F-FDG PET/CT due to inflamed concha bullosa.

Arens AI, Verbist BM, Hendrickx BW, de Geus-Oei LF, Oyen WJ.

Clin Nucl Med. 2012 May;37(5):509-10. doi: 10.1097/RLU.0b013e3182478846.

PMID:
22475907

Supplemental Content

Support Center